Anthony Schapira

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Anatomy

Physiology

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Schapira A H; Agid Y; Barone P; Jenner P; Lemke M R; Poewe W; Rascol O; Reichmann H; Tolosa E
Perspectives on recent advances in the understanding and treatment of Parkinson's disease.
Schapira A H V; Emre M; Jenner P; Poewe W
Levodopa in the treatment of Parkinson's disease.
Grünewald A; Gegg M E; Taanman J-W; King R H; Kock N; Klein C; Schapira A H V
Differential effects of PINK1 nonsense and missense mutations on mitochondrial function and morphology.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Anthony Schapira (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Schapira A H; Agid Y; Barone P; Jenner P; Lemke M R; Poewe W; Rascol O; Reichmann H; Tolosa E
Perspectives on recent advances in the understanding and treatment of Parkinson's disease.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2009;16(10):1090-9.
2009: Schapira A H V; Emre M; Jenner P; Poewe W
Levodopa in the treatment of Parkinson's disease.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2009;16(9):982-9.
2009: Grünewald A; Gegg M E; Taanman J-W; King R H; Kock N; Klein C; Schapira A H V
Differential effects of PINK1 nonsense and missense mutations on mitochondrial function and morphology.
Experimental neurology 2009;219(1):266-73.
2009: Bhattacharyya Sanjeev; Schapira Anthony H; Mikhailidis Dimitri P; Davar Joseph
Drug-induced fibrotic valvular heart disease.
Lancet 2009;374(9689):577-85.
2009: Schapira Anthony H V
Etiology and pathogenesis of Parkinson disease.
Neurologic clinics 2009;27(3):583-603, v.
2009: Chau Kai-Yin; Ching Hey Long; Schapira Anthony H V; Cooper J Mark
Relationship between alpha synuclein phosphorylation, proteasomal inhibition and cell death: relevance to Parkinson's disease pathogenesis.
Journal of neurochemistry 2009;110(3):1005-13.
2009: Chaudhuri K Ray; Schapira Anthony H V
Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment.
Lancet neurology 2009;8(5):464-74.
2009: Cano Stefan J; Riazi Afsane; Schapira Anthony H V; Cooper J Mark; Hobart Jeremy C
Friedreich's ataxia impact scale: a new measure striving to provide the flexibility required by today's studies.
Movement disorders : official journal of the Movement Disorder Society 2009;24(7):984-92.
2009: Chau Kai-Yin; Korlipara L V Prasad; Cooper J Mark; Schapira Anthony H V
Protection against paraquat and A53T alpha-synuclein toxicity by cabergoline is partially mediated by dopamine receptors.
Journal of the neurological sciences 2009;278(1-2):44-53.
2009: Schapira Anthony H V
Molecular and clinical pathways to neuroprotection of dopaminergic drugs in Parkinson disease.
Neurology 2009;72(7 Suppl):S44-50.
2009: Taanman Jan-Willem; Daras Mariza; Albrecht Juliane; Davie Charles A; Mallam Elizabeth A; Muddle John R; Weatherall Mark; Warner Thomas T; Schapira Anthony H V; Ginsberg Lionel
Characterization of a novel TYMP splice site mutation associated with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE).
Neuromuscular disorders : NMD 2009;19(2):151-4.
2009: Taanman Jan-Willem; Rahman Shamima; Pagnamenta Alistair T; Morris Andrew A M; Bitner-Glindzicz Maria; Wolf Nicole I; Leonard James V; Clayton Peter T; Schapira Anthony H V
Analysis of mutant DNA polymerase gamma in patients with mitochondrial DNA depletion.
Human mutation 2009;30(2):248-54.
2009: Schapira Anthony H V
Neurobiology and treatment of Parkinson's disease.
Trends in pharmacological sciences 2009;30(1):41-7.
2009: Obeso Jose A; Schapira Anthony H
Compensatory mechanisms in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2009;24(1):153-4.
2009: Gallagher David A; Schapira Anthony H V
Etiopathogenesis and treatment of Parkinson's disease.
Current topics in medicinal chemistry 2009;9(10):860-8.
2009: Gegg Matthew E; Cooper J Mark; Schapira Anthony H V; Taanman Jan-Willem
Silencing of PINK1 expression affects mitochondrial DNA and oxidative phosphorylation in dopaminergic cells.
PloS one 2009;4(3):e4756.
2008: Olanow C Warren; Kieburtz Karl; Schapira Anthony H V
Why have we failed to achieve neuroprotection in Parkinson's disease?
Annals of neurology 2008;64 Suppl 2():S101-10.
2008: Schapira Anthony H V; Olanow C Warren
Drug selection and timing of initiation of treatment in early Parkinson's disease.
Annals of neurology 2008;64 Suppl 2():S47-55.
2008: Cooper J M; Korlipara L V P; Hart P E; Bradley J L; Schapira A H V
Coenzyme Q10 and vitamin E deficiency in Friedreich's ataxia: predictor of efficacy of vitamin E and coenzyme Q10 therapy.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2008;15(12):1371-9.
2008: Healy D G; Wood N W; Schapira A H V
Test for LRRK2 mutations in patients with Parkinson's disease.
Practical neurology 2008;8(6):381-5.
2008: Schapira Anthony H V
Mitochondrial dysfunction in neurodegenerative diseases.
Neurochemical research 2008;33(12):2502-9.
2008: Tan E K; Schapira A H
Hunting for genes in essential tremor.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2008;15(9):889-90.
2008: Iravani Mahmoud M; Sadeghian Mona; Leung Clement C M; Tel Banu C; Rose Sarah; Schapira Anthony H; Jenner Peter
Continuous subcutaneous infusion of pramipexole protects against lipopolysaccharide-induced dopaminergic cell death without affecting the inflammatory response.
Experimental neurology 2008;212(2):522-31.
2008: Schapira Anthony H V
Rasagiline in neurodegeneration.
Experimental neurology 2008;212(2):255-7.
2008: Healy Daniel G; Falchi Mario; O'Sullivan Sean S; Bonifati Vincenzo; Durr Alexandra; Bressman Susan; Brice Alexis; Aasly Jan; Zabetian Cyrus P; Goldwurm Stefano; Ferreira Joaquim J; Tolosa Eduardo; Kay Denise M; Klein Christine; Williams David R; Marras Connie; Lang Anthony E; Wszolek Zbigniew K; Berciano Jose; Schapira Anthony H V; Lynch Timothy; Bhatia Kailash P; Gasser Thomas; Lees Andrew J; Wood Nicholas W;
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study.
Lancet neurology 2008;7(7):583-90.
2008: DiFrancesco Jacopo C; Cooper J Mark; Lam Amanda; Hart Paul E; Tremolizzo Lucio; Ferrarese Carlo; Schapira Antony H
MELAS mitochondrial DNA mutation A3243G reduces glutamate transport in cybrids cell lines.
Experimental neurology 2008;212(1):152-6.
2008: Grosset Donald G; Schapira Anthony H
Timing the initiation of treatment in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 2008;79(6):615.
2008: Rohrer J D; Schapira A H
Transient Horner's syndrome during lumbar epidural anaesthesia.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2008;15(5):530-1.
2008: Yamamoto Mitsutoshi; Schapira Anthony H V
Dopamine agonists in Parkinson's disease.
Expert review of neurotherapeutics 2008;8(4):671-7.
2008: Schapira A H V
Progress in neuroprotection in Parkinson's disease.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2008;15 Suppl 1():5-13.
2008: Schapira A H V
The scientific and clinical basis for future therapies in Parkinson's disease.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2008;15 Suppl 1():v.
2008: Bet L; Bareggi S R; Pacei F; Bondiolotti G; Meola G; Schapira A H V
Bimodal administration of entacapone in Parkinson's disease patients improves motor control.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2008;15(3):268-73.
2008: Tan E K; Schapira A H
Uniting Chinese across Asia: the LRRK2 Gly2385Arg risk variant.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2008;15(3):203-4.
2008: Martinez Carlos; Finnern Henrik Walter; Rietbrock Stephan; Eaton Susan; Chaudhuri Kallol Ray; Schapira Anthony H V
Patterns of treatment for restless legs syndrome in primary care in the United Kingdom.
Clinical therapeutics 2008;30(2):405-18.
2008: Schapira A H
Progress in Parkinson's disease.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2008;15(1):1.
2008: Schapira Anthony H V
Mitochondria in the aetiology and pathogenesis of Parkinson's disease.
Lancet neurology 2008;7(1):97-109.
2008: Schapira Anthony H V
The clinical relevance of levodopa toxicity in the treatment of Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2008;23 Suppl 3():S515-20.
2007: Giladi Nir; Boroojerdi Babak; Korczyn Amos D; Burn David J; Clarke Carl E; Schapira Anthony H V;
Rotigotine transdermal patch in early Parkinson's disease: a randomized, double-blind, controlled study versus placebo and ropinirole.
Movement disorders : official journal of the Movement Disorder Society 2007;22(16):2398-404.
2007: Simonson William; Hauser Robert A; Schapira Anthony H V
Role of the pharmacist in the effective management of wearing-off in Parkinson's disease.
The Annals of pharmacotherapy 2007;41(11):1842-9.
2007: Chaudhuri Kallol Ray; Martinez-Martin Pablo; Brown Richard G; Sethi Kapil; Stocchi Fabrizio; Odin Per; Ondo William; Abe Kazuo; Macphee Graeme; Macmahon Doug; Barone Paolo; Rabey Martin; Forbes Alison; Breen Kieran; Tluk Susanne; Naidu Yogini; Olanow Warren; Williams Adrian J; Thomas Sue; Rye David; Tsuboi Yoshio; Hand Annette; Schapira Anthony H V
The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot study.
Movement disorders : official journal of the Movement Disorder Society 2007;22(13):1901-11.
2007: Schapira Anthony H V
Future directions in the treatment of Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2007;22 Suppl 17():S385-91.
2007: Turner Christopher; Cooper J Mark; Schapira Anthony H V
Clinical correlates of mitochondrial function in Huntington's disease muscle.
Movement disorders : official journal of the Movement Disorder Society 2007;22(12):1715-21.
2007: Schapira Anthony H V
Treatment options in the modern management of Parkinson disease.
Archives of neurology 2007;64(8):1083-8.
2007: Martinez-Martin Pablo; Schapira Anthony H V; Stocchi Fabrizio; Sethi Kapil; Odin Per; MacPhee Graeme; Brown Richard G; Naidu Yogini; Clayton Lisa; Abe Kazuo; Tsuboi Yoshio; MacMahon Dough; Barone Paolo; Rabey Martin; Bonuccelli Ubaldo; Forbes Alison; Breen Kieran; Tluk Susanne; Olanow C Warren; Thomas Sue; Rye David; Hand Annette; Williams Adrian J; Ondo William; Chaudhuri K Ray
Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients.
Movement disorders : official journal of the Movement Disorder Society 2007;22(11):1623-9.
2007: Schapira A H V
Mitochondrial dysfunction in Parkinson's disease.
Cell death and differentiation 2007;14(7):1261-6.
2007: Cooper J M; Schapira A H V
Friedreich's ataxia: coenzyme Q10 and vitamin E therapy.
Mitochondrion 2007;7 Suppl():S127-35.
2007: Ginsberg Lionel; Schapira Anthony H V; Taanman Jan-Willem
Relapsing neuropathy in an 18-year-old woman.
Lancet neurology 2007;6(2):192-8.
2007: Schapira Anthony H V
Mitochondria in the etiology of Parkinson's disease.
Handbook of clinical neurology / edited by P.J. Vinken and G.W. Bruyn 2007;83():479-91.
2006: Olanow C Warren; Schapira Anthony H V; LeWitt Peter A; Kieburtz Karl; Sauer Dirk; Olivieri Gianfranco; Pohlmann Harald; Hubble Jean
TCH346 as a neuroprotective drug in Parkinson's disease: a double-blind, randomised, controlled trial.
Lancet neurology 2006;5(12):1013-20.
2006: Stacy Mark; Hauser Robert; Oertel Wolfgang; Schapira Anthony; Sethi Kapil; Stocchi Fabrizio; Tolosa Eduardo
End-of-dose wearing off in Parkinson disease: a 9-question survey assessment.
Clinical neuropharmacology 2006;29(6):312-21.
2006: Schapira Anthony H V; Bezard Erwan; Brotchie Jonathan; Calon Frédéric; Collingridge Graham L; Ferger Borris; Hengerer Bastian; Hirsch Etienne; Jenner Peter; Le Novère Nicolas; Obeso José A; Schwarzschild Michael A; Spampinato Umberto; Davidai Giora
Novel pharmacological targets for the treatment of Parkinson's disease.
Nature reviews. Drug discovery 2006;5(10):845-54.
2006: Schapira A H V
RLS patients: who are they?
European journal of neurology : the official journal of the European Federation of Neurological Societies 2006;13 Suppl 3():2-7.
2006: Schapira Anthony H V
The importance of LRRK2 mutations in Parkinson disease.
Archives of neurology 2006;63(9):1225-8.
2006: Riazi Afsane; Cano Stefan J; Cooper J Mark; Bradley Jane L; Schapira Anthony H V; Hobart Jeremy C
Coordinating outcomes measurement in ataxia research: do some widely used generic rating scales tick the boxes?
Movement disorders : official journal of the Movement Disorder Society 2006;21(9):1396-403.
2006: Schapira Anthony H V; Cleeter Michael W J; Muddle John R; Workman Jane M; Cooper J Mark; King Rosalind H M
Proteasomal inhibition causes loss of nigral tyrosine hydroxylase neurons.
Annals of neurology 2006;60(2):253-5.
2006: Schapira Anthony H V
Mitochondrial disease.
Lancet 2006;368(9529):70-82.
2006: Chaudhuri Kallol Ray; Martinez-Martin Pablo; Schapira Anthony H V; Stocchi Fabrizio; Sethi Kapil; Odin Per; Brown Richard G; Koller William; Barone Paolo; MacPhee Graeme; Kelly Linda; Rabey Martin; MacMahon Doug; Thomas Sue; Ondo William; Rye David; Forbes Alison; Tluk Susanne; Dhawan Vandana; Bowron Annette; Williams Adrian J; Olanow Charles W
International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study.
Movement disorders : official journal of the Movement Disorder Society 2006;21(7):916-23.
2006: Schapira Anthony H V
Etiology of Parkinson's disease.
Neurology 2006;66(10 Suppl 4):S10-23.
2006: Lodi Raffaele; Tonon Caterina; Calabrese Vittorio; Schapira Anthony H V
Friedreich's ataxia: from disease mechanisms to therapeutic interventions.
Antioxidants & redox signaling 2006;8(3-4):438-43.
2006: Schapira Anthony H V; Obeso Jose
Timing of treatment initiation in Parkinson's disease: a need for reappraisal?
Annals of neurology 2006;59(3):559-62.
2006: Chaudhuri K Ray; Healy Daniel G; Schapira Anthony H V;
Non-motor symptoms of Parkinson's disease: diagnosis and management.
Lancet neurology 2006;5(3):235-45.
2006: Iravani Mahmoud M; Haddon Claire O; Cooper J Mark; Jenner Peter; Schapira Anthony H
Pramipexole protects against MPTP toxicity in non-human primates.
Journal of neurochemistry 2006;96(5):1315-21.
2006: Schapira A H V
The use of rasagiline in Parkinson's disease.
Journal of neural transmission. Supplementum 2006;(71):157-61.
2005: Cano Stefan J; Hobart Jeremy C; Hart Paul E; Korlipara L V Prasad; Schapira Anthony H V; Cooper J Mark
International Cooperative Ataxia Rating Scale (ICARS): appropriate for studies of Friedreich's ataxia?
Movement disorders : official journal of the Movement Disorder Society 2005;20(12):1585-91.
2005: Schapira A H V
Present and future drug treatment for Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 2005;76(11):1472-8.
2005: Schapira Anthony; Bate Guy; Kirkpatrick Peter
Rasagiline.
Nature reviews. Drug discovery 2005;4(8):625-6.
2005: Lo Soo; Tolner Berend; Taanman Jan-Willem; Cooper J Mark; Gu Mei; Hartley John A; Schapira Anthony H V; Hochhauser Daniel
Assessment of the significance of mitochondrial DNA damage by chemotherapeutic agents.
International journal of oncology 2005;27(2):337-44.
2005: Strand Andrew D; Aragaki Aaron K; Shaw Dennis; Bird Thomas; Holton Janice; Turner Christopher; Tapscott Stephen J; Tabrizi Sarah J; Schapira Anthony H; Kooperberg Charles; Olson James M
Gene expression in Huntington's disease skeletal muscle: a potential biomarker.
Human molecular genetics 2005;14(13):1863-76.
2005: Tabrizi S J; Blamire A M; Manners D N; Rajagopalan B; Styles P; Schapira A H V; Warner T T
High-dose creatine therapy for Huntington disease: a 2-year clinical and MRS study.
Neurology 2005;64(9):1655-6.
2005: Baracca Alessandra; Solaini Giancarlo; Sgarbi Gianluca; Lenaz Giorgio; Baruzzi Agostino; Schapira Anthony H V; Martinuzzi Andrea; Carelli Valerio
Severe impairment of complex I-driven adenosine triphosphate synthesis in leber hereditary optic neuropathy cybrids.
Archives of neurology 2005;62(5):730-6.
2005: Danielson Steven R; Carelli Valerio; Tan Guolin; Martinuzzi Andrea; Schapira Anthony H V; Savontaus Marja-Liisa; Cortopassi Gino A
Isolation of transcriptomal changes attributable to LHON mutations and the cybridization process.
Brain : a journal of neurology 2005;128(Pt 5):1026-37.
2005: Hart Paul E; Lodi Raffaele; Rajagopalan Bheeshma; Bradley Jane L; Crilley Jenifer G; Turner Christopher; Blamire Andrew M; Manners David; Styles Peter; Schapira Anthony H V; Cooper J Mark
Antioxidant treatment of patients with Friedreich ataxia: four-year follow-up.
Archives of neurology 2005;62(4):621-6.
2005: Taanman Jan-Willem; Schapira Anthony H V
Analysis of the trinucleotide CAG repeat from the DNA polymerase gamma gene (POLG) in patients with Parkinson's disease.
Neuroscience letters 2005;376(1):56-9.
2004: Gu Mei; Iravani M M; Cooper J Mark; King Diane; Jenner Peter; Schapira Anthony H V
Pramipexole protects against apoptotic cell death by non-dopaminergic mechanisms.
Journal of neurochemistry 2004;91(5):1075-81.
2004: Chaudhuri K Ray; Forbes Alison; Grosset Donald; Lees Andrew; Shneerson John; Schapira Anthony; Stillman Paul; Williams Adrian
Diagnosing restless legs syndrome (RLS) in primary care.
Current medical research and opinion 2004;20(11):1785-95.
2004: Schapira Anthony H
Excessive daytime sleepiness in Parkinson's disease.
Neurology 2004;63(8 Suppl 3):S24-7.
2004: Beretta Simone; Mattavelli Laura; Sala Gessica; Tremolizzo Lucio; Schapira Anthony H V; Martinuzzi Andrea; Carelli Valerio; Ferrarese Carlo
Leber hereditary optic neuropathy mtDNA mutations disrupt glutamate transport in cybrid cell lines.
Brain : a journal of neurology 2004;127(Pt 10):2183-92.
2004: Orth M; Tabrizi S J; Tomlinson C; Messmer K; Korlipara L V P; Schapira A H V; Cooper J M
G209A mutant alpha synuclein expression specifically enhances dopamine induced oxidative damage.
Neurochemistry international 2004;45(5):669-76.
2004: Page R A; Davie C A; MacManus D; Miszkiel K A; Walshe J M; Miller D H; Lees A J; Schapira A H V
Clinical correlation of brain MRI and MRS abnormalities in patients with Wilson disease.
Neurology 2004;63(4):638-43.
2004: Schapira Anthony H V
Disease modification in Parkinson's disease.
Lancet neurology 2004;3(6):362-8.
2004: Wilkinson Philip A; Crosby Andrew H; Turner Christopher; Bradley Lloyd J; Ginsberg Lionel; Wood Nicholas W; Schapira Anthony H; Warner Thomas T
A clinical, genetic and biochemical study of SPG7 mutations in hereditary spastic paraplegia.
Brain : a journal of neurology 2004;127(Pt 5):973-80.
2004: McCabe D J H; Turner N C; Chao D; Leff A; Gregson N A; Womersley H J; Mak I; Perkin G D; Schapira A H V
Paraneoplastic "stiff person syndrome" with metastatic adenocarcinoma and anti-Ri antibodies.
Neurology 2004;62(8):1402-4.
2004: Bradley J L; Homayoun S; Hart P E; Schapira A H V; Cooper J M
Role of oxidative damage in Friedreich's ataxia.
Neurochemical research 2004;29(3):561-7.
2004: Korlipara L V Prasad; Cooper J Mark; Schapira Anthony H V
Differences in toxicity of the catechol-O-methyl transferase inhibitors, tolcapone and entacapone to cultured human neuroblastoma cells.
Neuropharmacology 2004;46(4):562-9.
2004: Rafique R; Schapira A H V; Coper J M
Mitochondrial respiratory chain dysfunction in ageing; influence of vitamin E deficiency.
Free radical research 2004;38(2):157-65.
2004: Schapira Anthony H V; Olanow C Warren
Neuroprotection in Parkinson disease: mysteries, myths, and misconceptions.
JAMA : the journal of the American Medical Association 2004;291(3):358-64.
2004: Schapira Anthony; Lodi Raffaele
Assessment of in vitro and in vivo mitochondrial function in Friedreich's ataxia and Huntington's disease.
Methods in molecular biology (Clifton, N.J.) 2004;277():293-307.
2004: Schapira Anthony H V
Restless legs syndrome: an update on treatment options.
Drugs 2004;64(2):149-58.
2003: Orth M; Tabrizi S J; Schapira A H V; Cooper J M
Alpha-synuclein expression in HEK293 cells enhances the mitochondrial sensitivity to rotenone.
Neuroscience letters 2003;351(1):29-32.
2003: Lodi Raffaele; Rajagopalan Bheeshma; Schapira Anthony H V; Cooper J Mark
Cardiac bioenergetics in Friedreich's ataxia.
Annals of neurology 2003;54(4):552; author reply 552-3.
2003: Orth M; Cooper J M; Bates G P; Schapira A H V
Inclusion formation in Huntington's disease R6/2 mouse muscle cultures.
Journal of neurochemistry 2003;87(1):1-6.
2003: Schapira A H V
Disease-modifying strategies and challenges in PD: interactive breakout sessions.
Neurology 2003;61(6 Suppl 3):S56-63.
2003: Schapira A H V
Neuroprotection in PD--a role for dopamine agonists?
Neurology 2003;61(6 Suppl 3):S34-42.
2003: Wilkinson P A; Crosby A H; Turner C; Patel H; Wood N W; Schapira A H; Warner T T
A clinical and genetic study of SPG5A linked autosomal recessive hereditary spastic paraplegia.
Neurology 2003;61(2):235-8.
2003: Tabrizi S J; Blamire A M; Manners D N; Rajagopalan B; Styles P; Schapira A H V; Warner T T
Creatine therapy for Huntington's disease: clinical and MRS findings in a 1-year pilot study.
Neurology 2003;61(1):141-2.
2003: Miller Robert F; Shahmonesh Maryam; Hanna Michael G; Unwin Robert J; Schapira Anthony H V; Weller Ian V D
Polyphenotypic expression of mitochondrial toxicity caused by nucleoside reverse transcriptase inhibitors.
Antiviral therapy 2003;8(3):253-7.
2003: Ghelli Anna; Zanna Claudia; Porcelli Anna Maria; Schapira Anthony H V; Martinuzzi Andrea; Carelli Valerio; Rugolo Michela
Leber's hereditary optic neuropathy (LHON) pathogenic mutations induce mitochondrial-dependent apoptotic death in transmitochondrial cells incubated with galactose medium.
The Journal of biological chemistry 2003;278(6):4145-50.
2003: Cooper J M; Schapira A H V
Friedreich's Ataxia: disease mechanisms, antioxidant and Coenzyme Q10 therapy.
BioFactors (Oxford, England) 2003;18(1-4):163-71.
2003: Schapira Anthony H V; Olanow C Warren
Rationale for the use of dopamine agonists as neuroprotective agents in Parkinson's disease.
Annals of neurology 2003;53 Suppl 3():S149-57; discussion S157-9.
2003: Warner Thomas T; Schapira Anthony H V
Genetic and environmental factors in the cause of Parkinson's disease.
Annals of neurology 2003;53 Suppl 3():S16-23; discussion S23-5.
2003: Olanow C Warren; Schapira Anthony H V; Agid Yves
Neuroprotection for Parkinson's disease: prospects and promises.
Annals of neurology 2003;53 Suppl 3():S1-2.
2002: Schapira A H V
Dopamine agonists and neuroprotection in Parkinson's disease.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2002;9 Suppl 3():7-14.
2002: Spacey Sian D; Valente Enza-Maria; Wali Gurusidheshwar M; Warner Thomas T; Jarman Paul R; Schapira Anthony H V; Dixon Peter H; Davis Mary B; Bhatia Kailash P; Wood Nicholas W
Genetic and clinical heterogeneity in paroxysmal kinesigenic dyskinesia: evidence for a third EKD gene.
Movement disorders : official journal of the Movement Disorder Society 2002;17(4):717-25.
2002: Schapira A H V
Primary and secondary defects of the mitochondrial respiratory chain.
Journal of inherited metabolic disease 2002;25(3):207-14.
2002: Bentley P I; Kimber T; Schapira A H V
Painful third nerve palsy in MS.
Neurology 2002;58(10):1532.
2002: Orth M; Schapira A H V
Mitochondrial involvement in Parkinson's disease.
Neurochemistry international 2002;40(6):533-41.
2002: Lodi R; Rajagopalan B; Bradley J L; Taylor D J; Crilley J G; Hart P E; Blamire A M; Manners D; Styles P; Schapira A H V; Cooper J M
Mitochondrial dysfunction in Friedreich's ataxia: from pathogenesis to treatment perspectives.
Free radical research 2002;36(4):461-6.
2002: Cock H R; Schapira A H V
A comparison of lorazepam and diazepam as initial therapy in convulsive status epilepticus.
QJM : monthly journal of the Association of Physicians 2002;95(4):225-31.
2002: Schapira Anthony H V
Neuroprotection and dopamine agonists.
Neurology 2002;58(4 Suppl 1):S9-18.
2002: Cock Hannah R; Tong Xin; Hargreaves Iain P; Heales Simon J R; Clark John B; Patsalos Phillip N; Thom Maria; Groves Michael; Schapira Anthony H V; Shorvon Simon D; Walker Matthew C
Mitochondrial dysfunction associated with neuronal death following status epilepticus in rat.
Epilepsy research 2002;48(3):157-68.
2002: Schapira A H V
The "new" mitochondrial disorders.
Journal of neurology, neurosurgery, and psychiatry 2002;72(2):144-9.
2002: Danielson Steven R; Wong Alice; Carelli Valerio; Martinuzzi Andrea; Schapira Anthony H V; Cortopassi Gino A
Cells bearing mutations causing Leber's hereditary optic neuropathy are sensitized to Fas-Induced apoptosis.
The Journal of biological chemistry 2002;277(8):5810-5.
2002: Orrell Richard W; Schapira Anthony H V
Mitochondria and amyotrophic lateral sclerosis.
International review of neurobiology 2002;53():411-26.
2002: Korlipara L V P; Schapira A H V
Parkinson's disease.
International review of neurobiology 2002;53():283-314.
2002: Davie C A; Schapira A H V
Wilson disease.
International review of neurobiology 2002;53():175-90.
2001: Lodi R; Rajagopalan B; Blamire A M; Cooper J M; Davies C H; Bradley J L; Styles P; Schapira A H
Cardiac energetics are abnormal in Friedreich ataxia patients in the absence of cardiac dysfunction and hypertrophy: an in vivo 31P magnetic resonance spectroscopy study.
Cardiovascular research 2001;52(1):111-9.
2001: Bhatia K; Brooks D J; Burn D J; Clarke C E; Grosset D G; MacMahon D G; Playfer J; Schapira A H; Stewart D; Williams A C;
Updated guidelines for the management of Parkinson's disease.
Hospital medicine (London, England : 1998) 2001;62(8):456-70.
2001: Cleeter M W; Cooper J M; Schapira A H
Nitric oxide enhances MPP(+) inhibition of complex I.
FEBS letters 2001;504(1-2):50-2.
2001: Kingsbury A E; Cooper M; Schapira A H; Foster O J
Metabolic enzyme expression in dopaminergic neurons in Parkinson's disease: an in situ hybridization study.
Annals of neurology 2001;50(2):142-9.
2001: Shults C W; Schapira A H
A cue to queue for CoQ?
Neurology 2001;57(3):375-6.
2001: Williams S L; Scholte H R; Gray R G; Leonard J V; Schapira A H; Taanman J W
Immunological phenotyping of fibroblast cultures from patients with a mitochondrial respiratory chain deficit.
Laboratory investigation; a journal of technical methods and pathology 2001;81(8):1069-77.
2001: Rafique R; Schapira A H; Cooper J M
Sensitivity of respiratory chain activities to lipid peroxidation: effect of vitamin E deficiency.
The Biochemical journal 2001;357(Pt 3):887-92.
2001: Sharma P; Wang T; Brown M J; Schapira A H
Fits and strokes.
Lancet 2001;358(9276):120.
2001: Lodi R; Hart P E; Rajagopalan B; Taylor D J; Crilley J G; Bradley J L; Blamire A M; Manners D; Styles P; Schapira A H; Cooper J M
Antioxidant treatment improves in vivo cardiac and skeletal muscle bioenergetics in patients with Friedreich's ataxia.
Annals of neurology 2001;49(5):590-6.
2001: Lodi R; Taylor D J; Schapira A H
Mitochondrial dysfunction in friedreich's ataxia.
Biological signals and receptors 2001;10(3-4):263-70.
2001: Orth M; Schapira A H
Mitochondria and degenerative disorders.
American journal of medical genetics 2001;106(1):27-36.
2001: Schapira A H
Causes of neuronal death in Parkinson's disease.
Advances in neurology 2001;86():155-62.
2001: Turner C; Schapira A H
Mitochondrial dysfunction in neurodegenerative disorders and ageing.
Advances in experimental medicine and biology 2001;487():229-51.
2000: Tabrizi S J; Orth M; Wilkinson J M; Taanman J W; Warner T T; Cooper J M; Schapira A H
Expression of mutant alpha-synuclein causes increased susceptibility to dopamine toxicity.
Human molecular genetics 2000;9(18):2683-9.
2000: Schapira A H
Mitochondrial disorders.
Current opinion in neurology 2000;13(5):527-32.
2000: Orth M; Tabrizi S J; Schapira A H
Sporadic inclusion body myositis not linked to prion protein codon 129 methionine homozygosity.
Neurology 2000;55(8):1235.
2000: Olanow W; Schapira A H; Rascol O
Continuous dopamine-receptor stimulation in early Parkinson's disease.
Trends in neurosciences 2000;23(10 Suppl):S117-26.
2000: Gu M; Cooper J M; Butler P; Walker A P; Mistry P K; Dooley J S; Schapira A H
Oxidative-phosphorylation defects in liver of patients with Wilson's disease.
Lancet 2000;356(9228):469-74.
2000: Lodi R; Schapira A H; Manners D; Styles P; Wood N W; Taylor D J; Warner T T
Abnormal in vivo skeletal muscle energy metabolism in Huntington's disease and dentatorubropallidoluysian atrophy.
Annals of neurology 2000;48(1):72-6.
2000: Münchau A; Valente E M; Shahidi G A; Eunson L H; Hanna M G; Quinn N P; Schapira A H; Wood N W; Bhatia K P
A new family with paroxysmal exercise induced dystonia and migraine: a clinical and genetic study.
Journal of neurology, neurosurgery, and psychiatry 2000;68(5):609-14.
2000: Schapira A H
Sleep attacks (sleep episodes) with pergolide.
Lancet 2000;355(9212):1332-3.
2000: Olanow C W; Schapira A H; Roth T
Waking up to sleep episodes in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2000;15(2):212-5.
2000: Rahman S; Lake B D; Taanman J W; Hanna M G; Cooper J M; Schapira A H; Leonard J V
Cytochrome oxidase immunohistochemistry: clues for genetic mechanisms.
Brain : a journal of neurology 2000;123 Pt 3():591-600.
2000: Leonard J V; Schapira A H
Mitochondrial respiratory chain disorders I: mitochondrial DNA defects.
Lancet 2000;355(9200):299-304.
2000: Leonard J V; Schapira A H
Mitochondrial respiratory chain disorders II: neurodegenerative disorders and nuclear gene defects.
Lancet 2000;355(9201):389-94.
2000: Olanow C W; Schapira A H; Roth T
Falling asleep at the wheel: motor vehicle mishaps in people taking pramipexole and ropinirole.
Neurology 2000;54(1):274; author reply 276-7.
2000: Tabrizi S J; Workman J; Hart P E; Mangiarini L; Mahal A; Bates G; Cooper J M; Schapira A H
Mitochondrial dysfunction and free radical damage in the Huntington R6/2 transgenic mouse.
Annals of neurology 2000;47(1):80-6.
2000: Bradley J L; Blake J C; Chamberlain S; Thomas P K; Cooper J M; Schapira A H
Clinical, biochemical and molecular genetic correlations in Friedreich's ataxia.
Human molecular genetics 2000;9(2):275-82.
2000: Attimonelli M; Altamura N; Benne R; Brennicke A; Cooper J M; D'Elia D; Montalvo A; Pinto B; De Robertis M; Golik P; Knoop V; Lanave C; Lazowska J; Licciulli F; Malladi B S; Memeo F; Monnerot M; Pasimeni R; Pilbout S; Schapira A H; Sloof P; Saccone C
MitBASE : a comprehensive and integrated mitochondrial DNA database. The present status.
Nucleic acids research 2000;28(1):148-52.
2000: Schapira A H; Obeso J A; Olanow C W
The place of COMT inhibitors in the armamentarium of drugs for the treatment of Parkinson's disease.
Neurology 2000;55(11 Suppl 4):S65-8; discussion S69-71.
1999: Schapira A H
Mitochondria in the aetiology and pathogenesis of Parkinson's disease.
Parkinsonism & related disorders 1999;5(4):139-43.
1999: Schapira A H; Cock H R
Mitochondrial myopathies and encephalomyopathies.
European journal of clinical investigation 1999;29(10):886-98.
1999: Rahman S; Taanman J W; Cooper J M; Nelson I; Hargreaves I; Meunier B; Hanna M G; García J J; Capaldi R A; Lake B D; Leonard J V; Schapira A H
A missense mutation of cytochrome oxidase subunit II causes defective assembly and myopathy.
American journal of human genetics 1999;65(4):1030-9.
1999: Lodi R; Cooper J M; Bradley J L; Manners D; Styles P; Taylor D J; Schapira A H
Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(20):11492-5.
1999: Blake J C; Taanman J W; Morris A M; Gray R G; Cooper J M; McKiernan P J; Leonard J V; Schapira A H
Mitochondrial DNA depletion syndrome is expressed in amniotic fluid cell cultures.
The American journal of pathology 1999;155(1):67-70.
1999: Cock H R; Cooper J M; Schapira A H
Functional consequences of the 3460-bp mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy.
Journal of the neurological sciences 1999;165(1):10-7.
1999: Newman B; Meola G; O'Donovan D G; Schapira A H; Kingston H
Proximal myotonic myopathy (PROMM) presenting as myotonia during pregnancy.
Neuromuscular disorders : NMD 1999;9(3):144-9.
1999: Schapira A H
Mitochondrial disorders.
Biochimica et biophysica acta 1999;1410(2):99-102.
1999: Schapira A H
Mitochondrial involvement in Parkinson's disease, Huntington's disease, hereditary spastic paraplegia and Friedreich's ataxia.
Biochimica et biophysica acta 1999;1410(2):159-70.
1999: Chalmers R M; Schapira A H
Clinical, biochemical and molecular genetic features of Leber's hereditary optic neuropathy.
Biochimica et biophysica acta 1999;1410(2):147-58.
1999: Schapira A H
Science, medicine, and the future: Parkinson's disease.
BMJ (Clinical research ed.) 1999;318(7179):311-4.
1999: Tabrizi S J; Cleeter M W; Xuereb J; Taanman J W; Cooper J M; Schapira A H
Biochemical abnormalities and excitotoxicity in Huntington's disease brain.
Annals of neurology 1999;45(1):25-32.
1999: Attimonelli M; Cooper J M; D'Elia D; de Montalvo A; De Robertis M; Lehväslaiho H; Malladi S B; Memeo F; Stevens K; Schapira A H; Saccone C
Update of the Human MitBASE database.
Nucleic acids research 1999;27(1):143-6.
1999: Attimonelli M; Altamura N; Benne R; Boyen C; Brennicke A; Carone A; Cooper J M; D'Elia D; de Montalvo A; de Pinto B; De Robertis M; Golik P; Grienenberger J M; Knoop V; Lanave C; Lazowska J; Lemagnen A; Malladi B S; Memeo F; Monnerot M; Pilbout S; Schapira A H; Sloof P; Slonimski P; Saccone C
MitBASE: a comprehensive and integrated mitochondrial DNA database.
Nucleic acids research 1999;27(1):128-33.
1999: Tabrizi S J; Schapira A H
Secondary abnormalities of mitochondrial DNA associated with neurodegeneration.
Biochemical Society symposium 1999;66():99-110.
1999: Cock H; Schapira A H
Mitochondrial DNA mutations and mitochondrial dysfunction in epilepsy.
Epilepsia 1999;40 Suppl 3():33-40.
1999: Schapira A H
Mitochondrial DNA in Parkinson's disease.
Advances in neurology 1999;80():233-7.
1998: Turner L F; Kaddoura S; Harrington D; Cooper J M; Poole-Wilson P A; Schapira A H
Mitochondrial DNA in idiopathic cardiomyopathy.
European heart journal 1998;19(11):1725-9.
1998: Lodi R; Taylor D J; Tabrizi S J; Hilton-Jones D; Squier M V; Seller A; Styles P; Schapira A H
Normal in vivo skeletal muscle oxidative metabolism in sporadic inclusion body myositis assessed by 31P-magnetic resonance spectroscopy.
Brain : a journal of neurology 1998;121 ( Pt 11)():2119-26.
1998: Seaton T A; Cooper J M; Schapira A H
Cyclosporin inhibition of apoptosis induced by mitochondrial complex I toxins.
Brain research 1998;809(1):12-7.
1998: Schapira A H
Inborn and induced defects of mitochondria.
Archives of neurology 1998;55(10):1293-6.
1998: Schapira A H; Gu M; Taanman J W; Tabrizi S J; Seaton T; Cleeter M; Cooper J M
Mitochondria in the etiology and pathogenesis of Parkinson's disease.
Annals of neurology 1998;44(3 Suppl 1):S89-98.
1998: Warner T T; Schapira A H
The role of the alpha-synuclein gene mutation in patients with sporadic Parkinson's disease in the United Kingdom.
Journal of neurology, neurosurgery, and psychiatry 1998;65(3):378-9.
1998: Schapira A H
Mitochondrial dysfunction in neurodegenerative disorders.
Biochimica et biophysica acta 1998;1366(1-2):225-33.
1998: Tabrizi S J; Cooper J M; Schapira A H
Mitochondrial DNA in focal dystonia: a cybrid analysis.
Annals of neurology 1998;44(2):258-61.
1998: Cock H R; Tabrizi S J; Cooper J M; Schapira A H
The influence of nuclear background on the biochemical expression of 3460 Leber's hereditary optic neuropathy.
Annals of neurology 1998;44(2):187-93.
1998: Gu M; Cooper J M; Taanman J W; Schapira A H
Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease.
Annals of neurology 1998;44(2):177-86.
1998: Hanna M G; Stewart J; Schapira A H; Wood N W; Morgan-Hughes J A; Murray N M
Salbutamol treatment in a patient with hyperkalaemic periodic paralysis due to a mutation in the skeletal muscle sodium channel gene (SCN4A).
Journal of neurology, neurosurgery, and psychiatry 1998;65(2):248-50.
1998: Hanna M G; Nelson I P; Rahman S; Lane R J; Land J; Heales S; Cooper M J; Schapira A H; Morgan-Hughes J A; Wood N W
Cytochrome c oxidase deficiency associated with the first stop-codon point mutation in human mtDNA.
American journal of human genetics 1998;63(1):29-36.
1998: Bhatia K; Brooks D J; Burn D J; Clarke C E; Playfer J; Sawle G V; Schapira A H; Stewart D; Williams A C
Guidelines for the management of Parkinson's disease. The Parkinson's Disease Consensus Working Group.
Hospital medicine (London, England : 1998) 1998;59(6):469-80.
1998: Gu M; Owen A D; Toffa S E; Cooper J M; Dexter D T; Jenner P; Marsden C D; Schapira A H
Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases.
Journal of the neurological sciences 1998;158(1):24-9.
1998: Schapira A H
Human complex I defects in neurodegenerative diseases.
Biochimica et biophysica acta 1998;1364(2):261-70.
1998: Morris A A; Taanman J W; Blake J; Cooper J M; Lake B D; Malone M; Love S; Clayton P T; Leonard J V; Schapira A H
Liver failure associated with mitochondrial DNA depletion.
Journal of hepatology 1998;28(4):556-63.
1998: Schapira A H
Colloidal gold staining and immunodetection in 2D protein mapping.
Methods in molecular biology (Clifton, N.J.) 1998;80():237-41.
1997: Rees J H; Ginsberg L; Schapira A H
Two pregnant women with vomiting and fits.
American journal of obstetrics and gynecology 1997;177(6):1539-40.
1997: Hawkes C H; Macdonald A M; Schapira A H
Use of general practitioner computerised records to create a population based twin sample: pilot study based on Parkinson's disease.
BMJ (Clinical research ed.) 1997;315(7121):1510-1.
1997: Seaton T A; Cooper J M; Schapira A H
Free radical scavengers protect dopaminergic cell lines from apoptosis induced by complex I inhibitors.
Brain research 1997;777(1-2):110-8.
1997: Lodi R; Taylor D J; Tabrizi S J; Kumar S; Sweeney M; Wood N W; Styles P; Radda G K; Schapira A H
In vivo skeletal muscle mitochondrial function in Leber's hereditary optic neuropathy assessed by 31P magnetic resonance spectroscopy.
Annals of neurology 1997;42(4):573-9.
1997: Warner T T; Schapira A H
Genetic counselling in mitochondrial diseases.
Current opinion in neurology 1997;10(5):408-12.
1997: Silva M T; Schapira A H; Jenner P
Unexpected findings of study of selegiline have not been treated with caution its authors advised.
BMJ (Clinical research ed.) 1997;315(7104):370.
1997: Taanman J W; Bodnar A G; Cooper J M; Morris A A; Clayton P T; Leonard J V; Schapira A H
Molecular mechanisms in mitochondrial DNA depletion syndrome.
Human molecular genetics 1997;6(6):935-42.
1997: Gu M; Gash M T; Cooper J M; Wenning G K; Daniel S E; Quinn N P; Marsden C D; Schapira A H
Mitochondrial respiratory chain function in multiple system atrophy.
Movement disorders : official journal of the Movement Disorder Society 1997;12(3):418-22.
1997: Schapira A H
Pathogenesis of Parkinson's disease.
Baillière's clinical neurology 1997;6(1):15-36.
1997: Cooper J M; Schapira A H
Mitochondrial dysfunction in neurodegeneration.
Journal of bioenergetics and biomembranes 1997;29(2):175-83.
1997: Schapira A H
Mitochondrial disorders: an overview.
Journal of bioenergetics and biomembranes 1997;29(2):105-7.
1997: Schapira A H; Warner T; Gash M T; Cleeter M W; Marinho C F; Cooper J M
Complex I function in familial and sporadic dystonia.
Annals of neurology 1997;41(4):556-9.
1997: Nashef L; Lake B D; Schapira A H
Congenital muscular dystrophy with severe retrocollis and mental retardation: a report of two siblings.
Journal of neurology, neurosurgery, and psychiatry 1997;62(3):279-81.
1997: Schapira A H
Mitochondrial disorders.
Current opinion in neurology 1997;10(1):43-7.
1997: Schapira A H
Mitochondrial function in Huntington's disease: clues for pathogenesis and prospects for treatment.
Annals of neurology 1997;41(2):141-2.
1997: Cock H; Mandler R; Ahmed W; Schapira A H
Neuromyelitis optica (Devic's syndrome): no association with the primary mitochondrial DNA mutations found in Leber hereditary optic neuropathy.
Journal of neurology, neurosurgery, and psychiatry 1997;62(1):85-7.
1997: Owen A D; Schapira A H; Jenner P; Marsden C D
Indices of oxidative stress in Parkinson's disease, Alzheimer's disease and dementia with Lewy bodies.
Journal of neural transmission. Supplementum 1997;51():167-73.
1996: Shergill J K; Cammack R; Cooper C E; Cooper J M; Mann V M; Schapira A H
Detection of nitrosyl complexes in human substantia nigra, in relation to Parkinson's disease.
Biochemical and biophysical research communications 1996;228(2):298-305.
1996: Schapira A H
Oxidative stress and mitochondrial dysfunction in neurodegeneration.
Current opinion in neurology 1996;9(4):260-4.
1996: Owen A D; Schapira A H; Jenner P; Marsden C D
Oxidative stress and Parkinson's disease.
Annals of the New York Academy of Sciences 1996;786():217-23.
1996: Gu M; Gash M T; Mann V M; Javoy-Agid F; Cooper J M; Schapira A H
Mitochondrial defect in Huntington's disease caudate nucleus.
Annals of neurology 1996;39(3):385-9.
1996: Chalmers R M; Govan G G; Schapira A H; Harding A E
HLA class I genotypes in Leber's hereditary optic neuropathy.
Journal of the neurological sciences 1996;135(2):173-5.
1996: Schapira A H
Neurotoxicity and the mechanisms of cell death in Parkinson's disease.
Advances in neurology 1996;69():161-5.
1995: Cock H R; Cooper J M; Schapira A H
The 14484 ND6 mtDNA mutation in Leber hereditary optic neuropathy does not affect fibroblast complex I activity.
American journal of human genetics 1995;57(6):1501-2.
1995: Smith P R; Cooper J M; Govan G G; Riordan-Eva P; Harding A E; Schapira A H
Antibodies to human optic nerve in Leber's hereditary optic neuropathy.
Journal of the neurological sciences 1995;130(2):134-8.
1995: Schapira A H
Nuclear and mitochondrial genetics in Parkinson's disease.
Journal of medical genetics 1995;32(6):411-4.
1995: Cooper J M; Daniel S E; Marsden C D; Schapira A H
L-dihydroxyphenylalanine and complex I deficiency in Parkinson's disease brain.
Movement disorders : official journal of the Movement Disorder Society 1995;10(3):295-7.
1995: Morgan-Hughes J A; Sweeney M G; Cooper J M; Hammans S R; Brockington M; Schapira A H; Harding A E; Clark J B
Mitochondrial DNA (mtDNA) diseases: correlation of genotype to phenotype.
Biochimica et biophysica acta 1995;1271(1):135-40.
1995: Schapira A H; Reichmann H
Electron transport chain defects in Alzheimer's disease.
Neurology 1995;45(3 Pt 1):599-600.
1995: Bodnar A G; Cooper J M; Leonard J V; Schapira A H
Respiratory-deficient human fibroblasts exhibiting defective mitochondrial DNA replication.
The Biochemical journal 1995;305 ( Pt 3)():817-22.
1995: Schapira A H
Oxidative stress in Parkinson's disease.
Neuropathology and applied neurobiology 1995;21(1):3-9.
1994: Mann V M; Cooper J M; Daniel S E; Srai K; Jenner P; Marsden C D; Schapira A H
Complex I, iron, and ferritin in Parkinson's disease substantia nigra.
Annals of neurology 1994;36(6):876-81.
1994: Schapira A H
Mitochondrial function and neurotoxicity.
Current opinion in neurology 1994;7(6):531-4.
1994: Hartley A; Stone J M; Heron C; Cooper J M; Schapira A H
Complex I inhibitors induce dose-dependent apoptosis in PC12 cells: relevance to Parkinson's disease.
Journal of neurochemistry 1994;63(5):1987-90.
1994: Govan G G; Smith P R; Kellar-Wood H; Schapira A H; Harding A E
HLA class II genotypes in Leber's hereditary optic neuropathy.
Journal of the neurological sciences 1994;126(2):193-6.
1994: Schapira A H; Cooper J M
Inborn and induced defects of the mitochondrial respiratory chain.
Biochemical Society transactions 1994;22(4):996-1001.
1994: Schapira A H; Marsden C D
British neurology: a national focus.
Journal of neurology, neurosurgery, and psychiatry 1994;57(9):1136.
1994: Taylor D J; Krige D; Barnes P R; Kemp G J; Carroll M T; Mann V M; Cooper J M; Marsden C D; Schapira A H
A 31P magnetic resonance spectroscopy study of mitochondrial function in skeletal muscle of patients with Parkinson's disease.
Journal of the neurological sciences 1994;125(1):77-81.
1994: Schapira A H
Advances in the understanding of the cause of Parkinson's disease.
Journal of the Royal Society of Medicine 1994;87(7):373-5.
1994: Cleeter M W; Cooper J M; Darley-Usmar V M; Moncada S; Schapira A H
Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases.
FEBS letters 1994;345(1):50-4.
1994: Schapira A H
Evidence for mitochondrial dysfunction in Parkinson's disease--a critical appraisal.
Movement disorders : official journal of the Movement Disorder Society 1994;9(2):125-38.
1994: Smith P R; Cooper J M; Govan G G; Harding A E; Schapira A H
Platelet mitochondrial function in Leber's hereditary optic neuropathy.
Journal of the neurological sciences 1994;122(1):80-3.
1994: Dexter D T; Sian J; Rose S; Hindmarsh J G; Mann V M; Cooper J M; Wells F R; Daniel S E; Lees A J; Schapira A H
Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease.
Annals of neurology 1994;35(1):38-44.
1994: Schapira A H; Marsden C D
Platelet mitochondrial DNA in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1994;9(1):119-21.
1994: Sweeney M G; Hammans S R; Duchen L W; Cooper J M; Schapira A H; Kennedy C R; Jacobs J M; Youl B D; Morgan-Hughes J A; Harding A E
Mitochondrial DNA mutation underlying Leigh's syndrome: clinical, pathological, biochemical, and genetic studies of a patient presenting with progressive myoclonic epilepsy.
Journal of the neurological sciences 1994;121(1):57-65.
1993: Small J R; Thomas P K; Schapira A H
Dorsal root ganglion proteins in Friedreich's ataxia.
Neuroscience letters 1993;163(2):182-4.
1993: Thomas P K; Cooper J M; King R H; Workman J M; Schapira A H; Goss-Sampson M A; Muller D P
Myopathy in vitamin E deficient rats: muscle fibre necrosis associated with disturbances of mitochondrial function.
Journal of anatomy 1993;183 ( Pt 3)():451-61.
1993: Harley A; Cooper J M; Schapira A H
Iron induced oxidative stress and mitochondrial dysfunction: relevance to Parkinson's disease.
Brain research 1993;627(2):349-53.
1993: Schapira A H
Mitochondrial cytopathies.
Current opinion in neurobiology 1993;3(5):760-7.
1993: Smith P R; Cooper J M; Govan G G; Harding A E; Schapira A H
Smoking and mitochondrial function: a model for environmental toxins.
The Quarterly journal of medicine 1993;86(10):657-60.
1993: Bodnar A G; Cooper J M; Holt I J; Leonard J V; Schapira A H
Nuclear complementation restores mtDNA levels in cultured cells from a patient with mtDNA depletion.
American journal of human genetics 1993;53(3):663-9.
1993: Schapira A H
The use of toxins to elucidate neural function and disease.
Current opinion in neurology and neurosurgery 1993;6(3):448-51.
1993: Schapira A H
Mitochondrial disorders.
Current opinion in genetics & development 1993;3(3):457-65.
1993: Schapira A H; Hartley A; Cleeter M W; Cooper J M
Free radicals and mitochondrial dysfunction in Parkinson's disease.
Biochemical Society transactions 1993;21(2):367-70.
1993: Cooper J M; Wischik C; Schapira A H
Mitochondrial function in Alzheimer's disease.
Lancet 1993;341(8850):969-70.
1993: Steiger M J; Tarnesby G; Gabe S; McLaughlin J; Schapira A H
Successful outcome of progressive multifocal leukoencephalopathy with cytarabine and interferon.
Annals of neurology 1993;33(4):407-11.
1993: Schapira A H
Mitochondrial complex I deficiency in Parkinson's disease.
Advances in neurology 1993;60():288-91.
1992: Krige D; Carroll M T; Cooper J M; Marsden C D; Schapira A H
Platelet mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson Disease Research Group.
Annals of neurology 1992;32(6):782-8.
1992: Jenner P; Schapira A H; Marsden C D
New insights into the cause of Parkinson's disease.
Neurology 1992;42(12):2241-50.
1992: Cooper J M; Mann V M; Schapira A H
Analyses of mitochondrial respiratory chain function and mitochondrial DNA deletion in human skeletal muscle: effect of ageing.
Journal of the neurological sciences 1992;113(1):91-8.
1992: Schapira A H; Cooper J M
Mitochondrial function in neurodegeneration and ageing.
Mutation research 1992;275(3-6):133-43.
1992: Cooper J M; Mann V M; Krige D; Schapira A H
Human mitochondrial complex I dysfunction.
Biochimica et biophysica acta 1992;1101(2):198-203.
1992: Schapira A H
MPTP and other Parkinson-inducing agents.
Current opinion in neurology and neurosurgery 1992;5(3):396-400.
1992: Haines A M; Cooper J M; Morgan-Hughes J A; Clark J B; Schapira A H
One-step immunoaffinity purification of complex I subunits from beef heart mitochondria.
Protein expression and purification 1992;3(3):223-7.
1992: Smith C A; Gough A C; Leigh P N; Summers B A; Harding A E; Maraganore D M; Sturman S G; Schapira A H; Williams A C;
Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease.
Lancet 1992;339(8806):1375-7.
1992: Mann V M; Cooper J M; Krige D; Daniel S E; Schapira A H; Marsden C D
Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease.
Brain : a journal of neurology 1992;115 ( Pt 2)():333-42.
1992: Mann V M; Cooper J M; Schapira A H
Quantitation of a mitochondrial DNA deletion in Parkinson's disease.
FEBS letters 1992;299(3):218-22.
1992: Cleeter M W; Cooper J M; Schapira A H
Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: evidence for free radical involvement.
Journal of neurochemistry 1992;58(2):786-9.
1992: Dexter D T; Jenner P; Schapira A H; Marsden C D
Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. The Royal Kings and Queens Parkinson's Disease Research Group.
Annals of neurology 1992;32 Suppl():S94-100.
1992: Jenner P; Dexter D T; Sian J; Schapira A H; Marsden C D
Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson's Disease Research Group.
Annals of neurology 1992;32 Suppl():S82-7.
1992: Schapira A H; Mann V M; Cooper J M; Krige D; Jenner P J; Marsden C D
Mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson's Disease Research Group.
Annals of neurology 1992;32 Suppl():S116-24.
1991: Gale A N; Gibbs J M; Schapira A H; Thomas P K
Neurology.
Postgraduate medical journal 1991;67(788):509-31.
1991: Morgan-Hughes J A; Cooper J M; Schapira A H; Sweeny M; Holt I J; Harding A E; Clark J B
The molecular pathology of human respiratory chain defects.
Revue neurologique 1991;147(6-7):450-4.
1990: Schapira A H; Mann V M; Cooper J M; Dexter D; Daniel S E; Jenner P; Clark J B; Marsden C D
Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease.
Journal of neurochemistry 1990;55(6):2142-5.
1990: Bet L; Bresolin N; Moggio M; Meola G; Prelle A; Schapira A H; Binzoni T; Chomyn A; Fortunato F; Cerretelli P
A case of mitochondrial myopathy, lactic acidosis and complex I deficiency.
Journal of neurology 1990;237(7):399-404.
1990: Mann V M; Cooper J M; Javoy-Agid F; Agid Y; Jenner P; Schapira A H
Mitochondrial function and parental sex effect in Huntington's disease.
Lancet 1990;336(8717):749.
1990: Morgan-Hughes J A; Cooper J M; Holt I J; Harding A E; Schapira A H; Clark J B
Mitochondrial myopathies: clinical defects.
Biochemical Society transactions 1990;18(4):523-6.
1990: Harding A E; Holt I J; Cooper J M; Schapira A H; Sweeney M; Clark J B; Morgan-Hughes J A
Mitochondrial myopathies: genetic defects.
Biochemical Society transactions 1990;18(4):519-22.
1990: Cooper J M; Schapira A H; Holt I J; Toscano A; Harding A E; Morgan-Hughes J A; Clark J B
Biochemical and molecular aspects of human mitochondrial respiratory chain disorders.
Biochemical Society transactions 1990;18(4):517-9.
1990: Morgan-Hughes J A; Schapira A H; Cooper J M; Holt I J; Harding A E; Clark J B
The molecular pathology of respiratory-chain dysfunction in human mitochondrial myopathies.
Biochimica et biophysica acta 1990;1018(2-3):217-22.
1990: Schapira A H; Cooper J M; Morgan-Hughes J A; Landon D N; Clark J B
Mitochondrial myopathy with a defect of mitochondrial-protein transport.
The New England journal of medicine 1990;323(1):37-42.
1990: Schapira A H; Cooper J M; Manneschi L; Vital C; Morgan-Hughes J A; Clark J B
A mitochondrial encephalomyopathy with specific deficiencies of two respiratory chain polypeptides and a circulating autoantibody to a mitochondrial matrix protein.
Brain : a journal of neurology 1990;113 ( Pt 2)():419-32.
1990: Schapira A H; Cooper J M; Dexter D; Clark J B; Jenner P; Marsden C D
Mitochondrial complex I deficiency in Parkinson's disease.
Journal of neurochemistry 1990;54(3):823-7.
1990: Schapira A H; Holt I J; Sweeney M; Harding A E; Jenner P; Marsden C D
Mitochondrial DNA analysis in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1990;5(4):294-7.
1989: Holt I J; Harding A E; Cooper J M; Schapira A H; Toscano A; Clark J B; Morgan-Hughes J A
Mitochondrial myopathies: clinical and biochemical features of 30 patients with major deletions of muscle mitochondrial DNA.
Annals of neurology 1989;26(6):699-708.
1989: Schapira A H; Llewelyn J G; Patel N J; Thomas P K
Polypeptide and glycoprotein abnormalities in dorsal root ganglia of streptozotocin-diabetic rats.
Journal of the neurological sciences 1989;94(1-3):147-61.
1989: Schapira A H; Cooper J M; Dexter D; Jenner P; Clark J B; Marsden C D
Mitochondrial complex I deficiency in Parkinson's disease.
Lancet 1989;1(8649):1269.
1989: Schapira A H
Mitochondrial myopathies.
BMJ (Clinical research ed.) 1989;298(6681):1127-8.
1988: Morgan-Hughes J A; Schapira A H; Cooper J M; Clark J B
Molecular defects of NADH-ubiquinone oxidoreductase (complex I) in mitochondrial diseases.
Journal of bioenergetics and biomembranes 1988;20(3):365-82.
1988: Schapira A H; Cooper J M; Morgan-Hughes J A; Patel S D; Cleeter M J; Ragan C I; Clark J B
Molecular basis of mitochondrial myopathies: polypeptide analysis in complex-I deficiency.
Lancet 1988;1(8584):500-3.
1988: Schapira A H; Keir G
Two-dimensional protein mapping by gold stain and immunoblotting.
Analytical biochemistry 1988;169(1):167-71.
1988: Morgan-Hughes J A; Schapira A H; Cooper J M; Hayes D J; Clark J B
Human mitochondrial respiratory chain deficiencies.
Australian paediatric journal 1988;24 Suppl 1():55-7.
1987: Morgan-Hughes J A; Cooper J M; Schapira A H; Hayes D J; Clark J B
The mitochondrial myopathies. Defects of the mitochondrial respiratory chain and oxidative phosphorylation system.
Electroencephalography and clinical neurophysiology. Supplement 1987;39():103-14.
1986: Schapira A H; Thomas P K
A case of recurrent idiopathic ophthalmoplegic neuropathy (Miller Fisher syndrome)
Journal of neurology, neurosurgery, and psychiatry 1986;49(4):463-4.
1985: Schapira A H; Gale A N
Pseudomonas osteitis causing cranial nerve palsies.
Journal of neurology, neurosurgery, and psychiatry 1985;48(12):1306-7.
1985: Schapira A H; Hutton R A
Platelet aggregation in myotonia.
Journal of the neurological sciences 1985;71(2-3):351-7.
1981: Schapira A H
How does lignocaine prevent ventricular fibrillation?
Lancet 1981;2(8256):1167-8.
1981: Schapira A H
Myasthenia gravis: a case report.
Age and ageing 1981;10(3):198-9.
1980: Schapira A H; Dyson P H
Vancomycin dose for pseudomembranous colitis.
Lancet 1980;2(8187):204.
1980: Baker P F; Schapira A H
Anaesthetics increase light emission from aequorin at constant ionised calcium.
Nature 1980;284(5752):168-9.
1977: Baker P F; Schapira A H
Measurement of ionic diffusion and mobility in axoplasm isolated from giant axons of Myxicola [proceedings].
The Journal of physiology 1977;266(1):5P.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Anthony Schapira

Research Profile (preview)

Disorders

Chemicals & Drugs

Anatomy

Physiology

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Anthony Schapira (preview)

All Publications